MRSA ID was evaluated for its ability to identify methicillin-resistant Staphylococcus aureus. A well-defined collection of staphylococci was used (n ؍ 998). The sensitivity after 24 h was 96.4%, increasing to 98.8% after 48 h. The specificity was 98.2% after 24 h and decreased to 89.7% after 48 h.Methicillin-resistant Staphylococcus aureus (MRSA) has emerged worldwide as a nosocomial pathogen of major importance, and the incidence of infections caused by MRSA continues to increase (1,14). The recent emergence of community-acquired MRSA poses an additional challenge for microbiological laboratories to improve their screening strategies (6). Laboratory-based screening for MRSA colonization of patients and health care workers remains a cornerstone of infection control measures to limit the spread of this organism (5). Methods to detect MRSA in clinical samples ideally should have high sensitivity and specificity combined with a short time to reporting of the results. To identify S. aureus from contaminated samples more easily and reliably, selective media have been developed. Ideally, selective media achieve isolation of S. aureus and detection of methicillin resistance in one single step (4).The purpose of this study is to evaluate the in vitro sensitivity and specificity of a recently developed medium called MRSA ID for the identification of MRSA using a well-defined collection of strains.A collection consisting of 271 MRSA strains, 249 methicillin-susceptible Staphylococcus aureus (MSSA) strains, and 478 coagulase-negative staphylococci (CNS) was used. The collection was described previously (2, 3). In short, the MRSA isolates were collected in The Netherlands between 1989 and 1998 and are part of the MRSA strain collection of the National Institute of Public Health and Environmental Protection, Bilthoven, The Netherlands. Identification of strains as S. aureus and as being methicillin resistant was performed by duplex PCR for the mecA gene and the coagulase gene (11). Strains were selected on the basis of their different phage types (8, 13; J. A. Rost, unpublished data). The MSSA strains were isolated from cultures of blood collected between May 1996 and January 2005 from patients at the following five hospitals: St. Elisabeth Hospital and Tweesteden Hospital, Tilburg, The Netherlands; Pasteur Hospital, Oosterhout, The Netherlands; Tweesteden Hospital, Waalwijk, The Netherlands; and Amphia Hospital, Breda, The Netherlands. Only one isolate was included per patient per admission period. Isolates were identified by a latex agglutination test (Staphaurex Plus; Murex Diagnostics Ltd., Dartford, England), by the detection of free coagulase by the tube coagulase test with rabbit plasma, and by the detection of DNase (DNase agar; Oxoid Ltd., Basingstoke, England). If the results of these tests were discordant, an AccuProbe culture identification test (Gen-Probe, San Diego, Calif.) was performed according to the manufacturer's instructions, and this was considered the "gold standard." The blood culture isolates were...